TrialDrug and alcohol review2025

Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open-label, non-randomised trial of long-acting injectable buprenorphine treatment in Australian custodial settings.

Bethany White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.